• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为用于肿瘤治疗的pH敏感药物载体的醋酸镁脂质体包裹阿霉素。

Encapsulation of doxorubicin in magnesium acetate liposomes as a pH-sensitive drug carrier for tumor therapy.

作者信息

Yang Yu, Zhang Miaomiao, Hong Zhiqiang, Mu Huiwen, Liu Ningang, Zhou Guangming, Miao Liyan, Li Shihong

机构信息

Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.

State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Suzhou Medical College of Soochow University, Suzhou 215123, China.

出版信息

iScience. 2025 Aug 9;28(9):113336. doi: 10.1016/j.isci.2025.113336. eCollection 2025 Sep 19.

DOI:10.1016/j.isci.2025.113336
PMID:40949098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12424428/
Abstract

The pH-sensitive drug release is an appealing strategy to enhance the therapy efficacy of anti-tumor liposomal drugs. In this study, we constructed the pH-sensitive magnesium-doxorubicin (Mg-DOX) liposomes by remote-loading of DOX into MgAc gradient liposomes. The prepared 100 nm Mg-DOX liposomes (Mg-DOX-Lip100) and folate receptor targeting Mg-DOX liposomes (FA-Mg-DOX-Lip100) were stable at physiological pH condition but gradually released DOX at acidic media. The FA-Mg-DOX-Lip100 exhibited much higher uptake by tumor cells and cytotoxicity than the Mg-DOX-Lip100. The Mg-DOX liposomes also showed stability in circulation in mice and delayed the growth of orthotopic EO771 tumor in C57BL/6 mice similar to Doxil-like liposomes at DOX dose of 5 mg/kg body weight every 4 days for 4 times, without observable morphologic change of the dissected organs at experiment endpoints. Thus, the pH-sensitive Mg-DOX liposomes have been successfully constructed and approved to be a potential antitumor delivery system to treat acidic tumors.

摘要

pH 敏感型药物释放是一种提高抗肿瘤脂质体药物治疗效果的有吸引力的策略。在本研究中,我们通过将阿霉素远程负载到醋酸镁梯度脂质体中构建了 pH 敏感型镁-阿霉素(Mg-DOX)脂质体。制备的 100 nm Mg-DOX 脂质体(Mg-DOX-Lip100)和叶酸受体靶向的 Mg-DOX 脂质体(FA-Mg-DOX-Lip100)在生理 pH 条件下稳定,但在酸性介质中逐渐释放阿霉素。与 Mg-DOX-Lip100 相比,FA-Mg-DOX-Lip100 在肿瘤细胞中的摄取和细胞毒性要高得多。Mg-DOX 脂质体在小鼠体内循环时也表现出稳定性,并且在每 4 天以 5 mg/kg 体重的剂量给予阿霉素,共给药 4 次的情况下,与类似 Doxil 的脂质体相似,可延缓 C57BL/6 小鼠原位 EO771 肿瘤的生长,在实验终点时解剖的器官未观察到形态学变化。因此,pH 敏感型 Mg-DOX 脂质体已成功构建,并被证明是一种治疗酸性肿瘤的潜在抗肿瘤递送系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/b73b1ef360e7/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/1bee163a2e12/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/4e4d56978e63/sc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/5b061176862b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/d01a74eb5055/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/9fdcaeeb86b4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/b73b1ef360e7/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/1bee163a2e12/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/4e4d56978e63/sc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/5b061176862b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/d01a74eb5055/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/9fdcaeeb86b4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4e/12424428/b73b1ef360e7/gr7.jpg

相似文献

1
Encapsulation of doxorubicin in magnesium acetate liposomes as a pH-sensitive drug carrier for tumor therapy.作为用于肿瘤治疗的pH敏感药物载体的醋酸镁脂质体包裹阿霉素。
iScience. 2025 Aug 9;28(9):113336. doi: 10.1016/j.isci.2025.113336. eCollection 2025 Sep 19.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Nanobody-functionalized liposomal doxorubicin: A novel strategy for angiogenesis suppression via VEGFR2 targeting.纳米抗体功能化脂质体阿霉素:一种通过靶向血管内皮生长因子受体2抑制血管生成的新策略。
Bioimpacts. 2025 Apr 6;15:30707. doi: 10.34172/bi.30707. eCollection 2025.
5
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
6
Corticosteroids for the treatment of Duchenne muscular dystrophy.用于治疗杜氏肌营养不良症的皮质类固醇
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD003725. doi: 10.1002/14651858.CD003725.pub4.
7
Multi-Focused Acoustic Radiation Force Impulse Modulation of Murine Hepatic Xenografts Enhances Nanoscale DOX@Lip Delivery and Therapeutic Effect.小鼠肝异种移植瘤的多聚焦声辐射力脉冲调制增强纳米级阿霉素脂质体递送及治疗效果
Int J Nanomedicine. 2025 Jun 12;20:7359-7373. doi: 10.2147/IJN.S522247. eCollection 2025.
8
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.伯氨喹或其他8-氨基喹啉用于减少恶性疟原虫传播。
Cochrane Database Syst Rev. 2014 Jun 30(6):CD008152. doi: 10.1002/14651858.CD008152.pub3.
9
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.左乙拉西坦添加治疗耐药性局灶性癫痫:Cochrane系统评价的更新版
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD001901. doi: 10.1002/14651858.CD001901.pub2.

本文引用的文献

1
Liposome-Based Drug Delivery Systems in Cancer Research: An Analysis of Global Landscape Efforts and Achievements.癌症研究中基于脂质体的药物递送系统:全球格局、努力与成就分析
Pharmaceutics. 2024 Mar 14;16(3):400. doi: 10.3390/pharmaceutics16030400.
2
Remote loading in liposome: a review of current strategies and recent developments.脂质体的远程加载:当前策略和最新进展综述。
J Liposome Res. 2024 Dec;34(4):658-670. doi: 10.1080/08982104.2024.2315449. Epub 2024 Feb 11.
3
Lipid-Based Nanotechnology: Liposome.基于脂质的纳米技术:脂质体。
Pharmaceutics. 2023 Dec 26;16(1):34. doi: 10.3390/pharmaceutics16010034.
4
Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols.脂质体作为药品上市批准的特征分析:分析方法、指导原则和标准化方案。
J Pharm Biomed Anal. 2023 Nov 30;236:115751. doi: 10.1016/j.jpba.2023.115751. Epub 2023 Sep 27.
5
Alpha-tocopheryl succinate and doxorubicin-loaded liposomes improve drug uptake and tumor accumulation in a murine breast tumor model.琥珀酸生育酚酯和阿霉素脂质体提高了在小鼠乳腺癌模型中的药物摄取和肿瘤积累。
Biomed Pharmacother. 2023 Sep;165:115034. doi: 10.1016/j.biopha.2023.115034. Epub 2023 Jun 23.
6
Effects of PEG-Linker Chain Length of Folate-Linked Liposomal Formulations on Targeting Ability and Antitumor Activity of Encapsulated Drug.叶酸偶联脂质体制剂的 PEG 连接链长度对包封药物靶向能力和抗肿瘤活性的影响。
Int J Nanomedicine. 2023 Mar 30;18:1615-1630. doi: 10.2147/IJN.S402418. eCollection 2023.
7
Folic Acid Enables Targeting Delivery of Lipodiscs by Circumventing IgM-Mediated Opsonization.叶酸通过绕过 IgM 介导的调理作用来实现脂微球的靶向递送。
Nano Lett. 2022 Aug 24;22(16):6516-6522. doi: 10.1021/acs.nanolett.2c01509. Epub 2022 Aug 9.
8
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches.刺激响应性脂质体纳米制剂在癌症治疗中的应用:临床前和临床方法。
J Control Release. 2022 Nov;351:50-80. doi: 10.1016/j.jconrel.2022.08.001. Epub 2022 Sep 20.
9
Metal complex-based liposomes: Applications and prospects in cancer diagnostics and therapeutics.基于金属配合物的脂质体:在癌症诊断和治疗中的应用和前景。
J Control Release. 2022 Aug;348:1066-1088. doi: 10.1016/j.jconrel.2022.06.012. Epub 2022 Jul 20.
10
Emerging roles for folate receptor FOLR1 in signaling and cancer.叶酸受体 FOLR1 在信号转导和癌症中的新兴作用。
Trends Endocrinol Metab. 2022 Mar;33(3):159-174. doi: 10.1016/j.tem.2021.12.003. Epub 2022 Jan 31.